Target Name: ENPEP
NCBI ID: G2028
Review Report on ENPEP Target / Biomarker Content of Review Report on ENPEP Target / Biomarker
ENPEP
Other Name(s): CD249 antigen | aminopeptidase A | Glutamyl aminopeptidase (isoform 1) | Differentiation antigen gp160 | CD249 | glutamyl aminopeptidase | gp160 | Glutamyl aminopeptidase, transcript variant 1 | APA | differentiation antigen gp160 | ENPEP variant 1 | AP-A | Aminopeptidase A | EAP | AMPE_HUMAN | Glutamyl aminopeptidase

CD249: A Protein Involved in Many Biological Processes and Cancer Development

ENPEP (CD249 antigen), also known as CD249, is a protein that is expressed in various tissues throughout the body, including the skin, hair, and nails. It is a member of the carbohydrate antigen 6 (CA6) family, which is characterized by the presence of a single constant region and a single variable region.

CD249 is a glycoprotein that consists of a single transmembrane domain and a cytoplasmic tail. It has a molecular weight of approximately 180 kDa and a pre-fusion molecular mass of approximately 160 kDa. CD249 is expressed in various tissues throughout the body, including the skin, hair, and nails, and is also found in the placenta, fetal brain, and heart.

CD249 is involved in many different biological processes in the body, including cell adhesion, migration, and invasion. It is a critical regulator of the migratory front, which is the outermost layer of the skin and other tissues and plays a key role in their development and maintenance.

CD249 has also been shown to be involved in many different types of cancer, including breast, ovarian, and prostate cancer. In these cancers, CD249 is often overexpressed and can serve as a drug target or biomarker. For example, some studies have shown that targeting CD249 with small molecules or antibodies has the potential to be an effective treatment for these cancers.

In addition to its potential as a drug target, CD249 has also been shown to be a useful biomarker for certain types of cancer. For example, some studies have shown that the level of CD249 in cancer cells can be used as a marker for the disease and can be used to track the effectiveness of certain treatments.

Overall, CD249 is a protein that is involved in many different biological processes in the body and has been shown to be involved in the development and progression of many types of cancer. Further research is needed to fully understand its role in these processes and to explore its potential as a drug target or biomarker.

Protein Name: Glutamyl Aminopeptidase

Functions: Regulates central hypertension through its calcium-modulated preference to cleave N-terminal acidic residues from peptides such as angiotensin II

The "ENPEP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ENPEP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ENPP1 | ENPP2 | ENPP3 | ENPP4 | ENPP5 | ENPP6 | ENPP7 | ENPP7P10 | ENPP7P12 | ENPP7P7 | ENSA | ENSAP2 | ENTHD1 | ENTPD1 | ENTPD1-AS1 | ENTPD2 | ENTPD3 | ENTPD3-AS1 | ENTPD4 | ENTPD5 | ENTPD6 | ENTPD7 | ENTPD8 | ENTR1 | ENTREP1 | ENTREP2 | ENTREP3 | env | ENY2 | EOGT | EOLA1 | EOLA1-DT | EOLA2 | EOLA2-DT | EOMES | EP300 | EP300-AS1 | EP400 | EP400P1 | EPAS1 | EPB41 | EPB41L1 | EPB41L1-AS1 | EPB41L2 | EPB41L3 | EPB41L4A | EPB41L4A-AS1 | EPB41L4A-DT | EPB41L4B | EPB41L5 | EPB42 | EPC1 | EPC2 | EPCAM | EPCAM-DT | EPDR1 | EPG5 | EPGN | EPHA1 | EPHA1-AS1 | EPHA10 | EPHA2 | EPHA2-AS1 | EPHA3 | EPHA4 | EPHA5 | EPHA5-AS1 | EPHA6 | EPHA7 | EPHA8 | EPHB1 | EPHB2 | EPHB3 | EPHB4 | EPHB6 | Ephrin Receptor | EPHX1 | EPHX2 | EPHX3 | EPHX4 | EPIC1 | EPIST | Epithelial Sodium Channel (ENaC) | EPM2A | EPM2A-DT | EPM2AIP1 | EPN1 | EPN2 | EPN3 | EPO | EPOP | EPOR | Epoxide Hydrolase | EPPIN | EPPK1 | EPRS1 | EPS15 | EPS15L1 | EPS8 | EPS8L1